DICL_CP_0317716 - DICL Database

Basic Molecular Information

Basic Information

DICL ID

DICL_CP_0317716

PubChem CID

1775

Molecular Formula

C₁₅H₁₂N₂O₂

Molecular Weight

252.273 g/mol

Synonyms/Alias

[phenytoin; 5;5-DIPHENYLHYDANTOIN; 57-41-0; Diphenylhydantoin; Dilantin; 5;5-diphenylimidazolidine-2;4-dione; Phenytoine; Zentropil; Epamin; Lepitoin; Dihydantoin; Aleviatin; Dilabid; Diphantoin; Diph...[phenytoin; 5;5-DIPHENYLHYDANTOIN; 57-41-0; Diphenylhydantoin; Dilantin; 5;5-diphenylimidazolidine-2;4-dione; Phenytoine; Zentropil; Epamin; Lepitoin; Dihydantoin; Aleviatin; Dilabid; Diphantoin; Diphenylan; Diphedan; Fenylepsin; Phentytoin; Sodanton; Difenin; Dihycon; Lehydan; Diphenylhydatanoin; Dantoinal; Di-Hydan; Dilantine; Dillantin; Diphenine; Diphentyn; Ditoinate; Elepsindon; Epilantin; Fenitoina; Fenytoine; Hidantilo; Hidantina; Hidantomin; Hydantoinal; Kessodanten; Phanantin; Phanatine; Phenatoine; Sodantoin; Sylantoic; Thilophenyl; Zentronal; Auranile; Dantinal; Dantoine; Difetoin; Difhydan; Dintoin; Dintoina; Diphedal; Diphenin; Enkelfel; Epifenyl; Epihydan; Fentoin; Hidantal; Hydantal; Idantoil; Idantoin; Labopal; Phentoin; Ritmenal; Saceril; Sanepil; Silantin; Solantin; Danten; Denyl; Epelin; Epinat; Epised; Eptal; Hidan; Lepsin; Oxylan; Ekko; Ictalis simple; Toin unicelles; Dilantin acid; Dantoinal klinos; Om-Hydantoine; Di-Phetine; Epdantoine simple; Hidantina vitoria; Gerot-epilan-D; Epilan-D; Neosidantoina; Comitoina; Hidantina senosian; Hydantol; Minetoin; Novantoina; Causoin; Convul; Di-Lan; Ekko capsules; Neos-Hidantoina; 2;4-Imidazolidinedione; 5;5-diphenyl-; Om hidantoina simple; TOIN; Phenhydanin; Phenytex; Phenytoinum; Sinergina; Sodanthon; Iphenylhydantoin; Phenytoin-Gerot; Difenilhidantoina; Fenytoin Dak; Didan TDC 250; Dilantin-125; Epdantoin Simple; Phenytoin AWD; Epilan D; 5;5-Diphenyl-2;4-imidazolidinedione; Diphenat; Hindatal; Hydantin; Epanutin; Fenitoina [INN-Spanish]; Phenytoine [INN-French]; Phenytoinum [INN-Latin]; Difenilhidantoina [Spanish]; Diphenylhydantoine [French]; 5;5-Dwufenylohydantoina; Antisacer; Fenantoin Mn Pharma; Diphenylhydantoine; Di-Lan (VAN); PHENYTOIN SODIUM; Diphenylhydantoin (VAN); Diphentoin; DILANTIN-30; Solantoin; Solantyl; Eptoin; DPH (VAN); 5;5-diphenyl hydantoin; 5;5-Diphenylimidazolidin-2;4-dione; 5;5-Diphenyl-imidazolidine-2;4-dione; 5;5-Diphenylhydantoin (IUPAC); 5;5-Dwufenylohydantoina [Polish]; Hydantoin; 5;5-diphenyl-; CCRIS 515; CHEBI:8107; NCI-C55765; 5;5-Diphenylhydantoin (phenytoin); AI3-52498; NSC-8722; Dilantin (TN); Novophenytoin; MFCD00005264; MLS000069789; Citrulliamon; DTXSID8020541; Phenitoin; 5;5-diphenyltetrahydro-1H-2;4-imidazoledione; Fenidantoin s; NSC8722; SM-88 COMPONENT PHENYTOIN; 6158TKW0C5; Epasmir 5; NCGC00021139-03; SMR000059026; Fenidantoin s; 5;5-DIPHENYLHYDANTOIN-D5 98 ATOM % D; DTXCID60541; Epasmir 5; Didan-tdc-250; CAS-57-41-0; phenytoin (PHN); component of Mebroin; fenidantoin s; epasmir 5; NSC 8722; EINECS 200-328-6; UNII-6158TKW0C5; SR-01000075211; IFLab1_000214; Fenidantoin s; HSDB 3160; Episar (Salt/Mix); Epasmir 5; Aladdin (Salt/Mix); Alepsin (Salt/Mix); Epsolin (Salt/Mix); Phenytoin (Lepitoin); Tacosal (Salt/Mix); Phenytoin [USAN:USP:INN:BAN:JAN]; Antisacer (Salt/Mix); Epdantoin (Salt/Mix); Epileptin (Salt/Mix); Hydantoin;5-diphenyl-; Spectrum_001105; Fenigramon (Salt/Mix); Citrullamon (Salt/Mix); Opera_ID_394; PHENYTOIN [INN]; PHENYTOIN [JAN]; 2; 5;5-diphenyl-; PHENYTOIN [MI]; CHEMBL16; PHENYTOIN [HSDB]; PHENYTOIN [IARC]; PHENYTOIN [USAN]; Spectrum2_001281; Spectrum3_000890; Spectrum4_000984; Spectrum5_001369; Lopac-D-4007; PHENYTOIN [VANDF]; Epitope ID:117723; PHENYTOIN [MART.]; D 4007; PHENYTOIN [USP-RS]; PHENYTOIN [WHO-DD]; PHENYTOIN [WHO-IP]; SCHEMBL3440; BIDD:PXR0090; Lopac0_000329; Lopac0_000378; Oprea1_373280; BSPBio_001437; KBioGR_001387; KBioSS_001585; MLS001074087; MLS002454401; BIDD:GT0625; DivK1c_000507; Soluble phenytoin (Salt/Mix); SPBio_001281; Phenytoin (JP17/USP/INN); Phenytoin; 1mg/ml in Methanol; GTPL2624; PHENYTOIN [ORANGE BOOK]; 2-hydroxy-5;5-diphenyl-3;5-dihydro-4H-imidazol-4-one; PHENYTOIN [EP MONOGRAPH]; PHENYTOIN [USP IMPURITY]; KBio1_000507; KBio2_001585; KBio2_004153; KBio2_006721; KBio3_001780; PHENYTOIN [USP MONOGRAPH]; WLN: T5MVMV EHJ ER& ER; 5;5-Diphenylhydantoin; >=99%; NINDS_000507; Phenytoin 1.0 mg/ml in Methanol; HMS1412J16; HMS1694O05; HMS1791H19; HMS1989H19; HMS2089E11; HMS2236J06; HMS3261K17; HMS3402H19; HMS3657O03; PHENYTOINUM [WHO-IP LATIN]; BCP05960; HY-B0448; Hydantoin; 5;5-diphenyl- (8CI); Tox21_110861; Tox21_202299; Tox21_300281; Tox21_500378; AC-376; BDBM50003655; BDBM50101816; s2525; STK058029; STK182871; STL454130; AKOS000416887; AKOS003245432; Tox21_110861_1; CCG-104011; CCG-221682; DB00252; LP00378; Phenytoin 1000 microg/mL in Methanol; 5;5-di(phenyl)imidazolidine-2;4-dione; IDI1_000507; IDI1_008433; NCGC00015342-01; NCGC00015342-02; NCGC00015342-03; NCGC00015342-04; NCGC00015342-05; NCGC00015342-06; NCGC00015342-07; NCGC00015342-08; NCGC00015342-09; NCGC00015342-10; NCGC00015342-11; NCGC00015342-12; NCGC00021139-01; NCGC00021139-02; NCGC00021139-04; NCGC00021139-05; NCGC00021139-06; NCGC00021139-07; NCGC00021139-08; NCGC00021139-09; NCGC00021139-10; NCGC00021139-11; NCGC00091492-01; NCGC00091492-02; NCGC00091492-03; NCGC00091492-04; NCGC00091492-05; NCGC00093810-01; NCGC00093810-02; NCGC00254135-01; NCGC00259848-01; NCGC00261063-01; 5;5-?Diphenyl-?2;4-?imidazolidinedione; 5;5-Diphenyl-1H-imidazolidine-2;4-dione; D0894; EU-0100378; NS00010290; SW203757-2; EN300-16818; 5;5-diphenylimidazolidine-2;4-dione;Phenytoin; C07443; D00512; E76094; 2;4-Imidazolidinedione; 5;5-diphenyl- (9CI); AB00374253-10; AB00374253-11; AB00374253_13; A831435; Q410400; SR-01000003141; SR-01000003141-8; SR-01000075211-2; W-105468; BRD-K55930204-001-02-7; BRD-K55930204-236-11-0; Z56786458; 4-hydroxy-5;5-diphenyl-1;5-dihydro-2H-imidazol-2-one; F0020-1370; Phenytoin; European Pharmacopoeia (EP) Reference Standard; Phenytoin; United States Pharmacopeia (USP) Reference Standard; Phenytoin; Pharmaceutical Secondary Standard; Certified Reference Material; Phenytoin for system suitability; European Pharmacopoeia (EP) Reference Standard; InChI=1/C15H12N2O2/c18-13-15(17-14(19)16-13;11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H;(H2;16;17;18;19]

InChI Key

CXOFVDLJLONNDW-UHFFFAOYSA-N

InChI

InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19...

IUPAC Name

5,5-diphenylimidazolidine-2,4-dione

CAS Number

57-41-0

Structure Information

Chemical Structure Visualization

SMILES Notation

2D Molecular Drawing

Carbon (C)

Hydrogen (H)

Oxygen (O)

Nitrogen (N)

Sulfur (S)

SDF

31 33 0 0 0 0 0 0 0 0999 V2000
3.2547 2.2521 -0.1017 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2124 1.3059 -1.1269 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2095 0.331...

Download SDF File (2676 bytes)

Experimental Data

Activity Data

Target Ion Channel

Sodium channel protein type 8 subunit alpha

Uniprot Accession Number

Q9UQD0

Function

Inhibitor

Species

Homo sapiens (Human)

IC₅₀

IC₅₀: 59820 nM

EC₅₀

N/A (Not available)

K_i

N/A (Not available)

K_d

N/A (Not available)

Inhibition

N/A (Not available)

Experimental Conditions

pH 7.5

Holding Potential

70 mV mV

Temperature

Room Temperature

Test Method

Patch-clamping

Test Species

Not specified

Binding Information

Binding Site

Not specified

Binding Site Residue

Not specified

Disease Information

Related Disease

Not specified

References

DOI

10.1111/epi.17149

URL

N/A (Not available)

PMID

35037706

Patent

N/A (Not available)

Computed Properties

Heavy Atom Count

Rotatable Bonds

logP

1.7696

Complexity

70.3384

TPSA (Å²)

58.2

H-Bond Donors

H-Bond Acceptors

Ring Count

New Search

Molecular Details

Basic Molecular Information

Basic Information

Structure Information

Chemical Structure Visualization

Experimental Data

Activity Data

Experimental Conditions

Binding Information

Disease Information

References

Computed Properties